The American College of Cardiology (ACC), based in Washington, D.C., is a nonprofit medical association established in 1949, with a mission to transform cardiovascular care and to improve heart health.
The ACC provides professional medical education, disseminates cardiovascular research, bestows credentials upon cardiovascular specialists, and develops health policy, standards, and clinical practice guidelines and tools for cardiovascular practice.
The ACC also has partnered with various organizations to create a variety of clinical and patient resources optimized for smartphones and tablets in a form of mobile apps.
Here, we list some of the best apps made by ACC.
AnticoagEvaluator app was created with the goal to assist clinicians to calculate the risk of stroke in patients on oral anticoagulation therapy.
The app provides specific numbers on stroke and bleeding risk, as well as benefits and risks of therapy with oral anticoagulants.
After allowing clinicians to enter patient's information, using the CHA2DS2-VASC and HAS-BLED scores,
the app automatically calculates the stroke risk and let clinicians choose/adjust the therapy.
AnticoagEvaluator app is available for Android and iOS for free.
BridgeAnticoag app is similar to AnticoagEvaluator app in terms of providing a guidance to clinicians on how to manage anticoagulation therapy.
However, BridgeAnticoag app is more specifically focused on patients with non-valvular atrial fibrillation who are to undergo invasive procedure or surgery.
Basically, BridgeAnticoag app assists providers who need to decide if their NVAF patients scheduled for procedure or surgery should have their anticoagulation stopped, bridged, or restarted.
BridgeAnticoag app is just like AnticoagEvaluator app is intended for non-valvular atrial fibrillation patients only, and should not be used to guide therapy in patients with mechanical or bioprosthetic valves.
The app is free and it is available for iOS and Android.
Statins are a group of cholesterol-lowering drugs and the most widely prescribed medications, due to their ability to prevent cardiovascular disease and to extend the life of cardiovascular patients by lowering the levels of LDL (the "bad") cholesterol in the bloodstream.
Statins are generally very well tolerated with a very low risk of serious side effects, however, statin intolerance may occur in some patients.
While some statin side effects, such as the potential risk of causing diabetes mellitus, cancer, and memory loss, have been debunked, other symptoms such as mild muscle pain, weakness, or cramps often called statin myopathies or myalgias, remain real problem caused by statin intolerance.
These statin intolerance problems, specifically statin myopathy, are comprehensively addressed in the Statin Intolerance app.
This app guides clinicians through the steps of treating and managing patients who report muscle symptoms, taking the patients' symptom history into consideration in order to determine if they are truly statin intolerant.
The app is available for free on Android and iOS.
In 2013, the American College of Cardiology and the American Heart Association published cholesterol management guidelines, the most current recommendations that address a comprehensive approach to prevent and reduce the risk of atherosclerotic cardiovascular disease.
Despite some controversial parts, these guidelines are still widely used by the medical community.
American College of Cardiology also developed the free ASCVD Risk Estimator app for Android and iOS, which works as a companion tool to the ACC/AHA guidelines, with the main purpose to estimate a patient's 10-year and lifetime risk for atherosclerotic cardiovascular disease (ASCVD), based on patient's gender, age, race, total cholesterol, HDL cholesterol, and systolic blood pressure, and medical history.
Statin Intolerance and ASCVD Risk Estimator apps are also available in the LDL-C Manager app which combines three ACC's cholesterol apps into one.
Besides ASCVD Risk Estimator that calculates pre-treatment ASCVD risk and determine if statin therapy is appropriate for a patient, Statin Intolerance that evaluates patient for possible statin intolerance, the app also includes LDL-C Lowering Therapy app/section that assess response to statin and considers other therapies.
LDL-C Manager app is also available for free on both Android and iOS devices.
In 2017, the American College of Cardiology (ACC) released new heart failure guidelines with revised terminology from the old systolic and diastolic heart failure to heart failure with preserved (HfpEF) and reduced (HFrEF) ejection fraction and updated evidence on the role of certain medications in the treatment of HFrEF.
They also developed a free TreatHF app which is designed for use by clinicians to help optimize pharmacological therapy for chronic symptomatic heart failure patients with reduced ejection fraction (HFrEF), specifically for stage C patients.
The advice in the app is derived from either 2013 ACC/AHA/HFSA Heart Failure Guideline and 2017 Guideline updates, or 2017 ACC's Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment.
TreatHF app is available for Android and iOS.
In 2015, a team of cardiothoracic surgeons and interventional cardiologists assembled by the Society for Thoracic Surgeons and the American College of Cardiology developed a calculator to estimate a patient's risk for dying in hospital following a TAVR procedure, which is also available in a form of a free mobile app for iOS and Android mobile devices called TAVR Risk Calculator.
The app helps clinicians calculate the in-hospital mortality risk of a prospective patient about to undergo transcatheter aortic valve replacement (TAVR) procedure.
The app allows clinicians to enter patient's relevant criteria, and based on the data entered, it provides clinicians with a report showing a predicted in-hospital mortality risk after TAVR procedure that can instantly be shared via email.
The ACC Guideline Clinical app allows clinicians caring for patients with cardiovascular disease to access the American College of Cardiology's clinical guideline recommendations and use interactive tools such as risk scores, dosing calculators, and algorithms.
Current guidelines and tools in the app cover various cardiovascular topics, including atrial fibrillation (AF), heart failure (HF), cholesterol, high blood pressure, cardiovascular risk, and more.
ACC Guideline Clinical app is free for Android and iOS devices.
CardioSmart Heart Explorer app was designed with a purpose to enhance the discussion between clinicians and their patients at the point of care, regarding most common heart problems and treatment options.
CardioSmart Heart Explorer is a multimedia app that offers a range of interactive animations, heart models, and videos to help patients visualize and understand the processes (conditions and treatments).
Previously, the app was available only to the members of the American College of Cardiology with a subscription, while the non-members had to pay $3.99 to use the app.
Meanwhile, the ACC made this app free to everyone, including cardiologists and other healthcare providers, as well as patients and their caregivers.